- abnormal testis morphology / IMPC
- abnormal lens morphology / IMPC
- decreased total retina thickness / IMPC
- decreased mean corpuscular hemoglobin concentration / IMPC
- abnormal spleen morphology / IMPC
- increased lean body mass / IMPC
- hyperactivity / IMPC
- decreased heart rate / IMPC
- increased startle reflex / IMPC
- decreased grip strength / IMPC
- abnormal vertebral arch morphology / IMPC
- increased grip strength / IMPC
- hyperplasia / IMPC
- increased circulating sodium level / IMPC
- decreased exploration in new environment / IMPC
- decreased total body fat amount / IMPC
- decreased circulating chloride level / IMPC
- decreased vertical activity / IMPC
- increased bone mineral content / IMPC
- abnormal cholesterol homeostasis / IMPC
- abnormal retina inner nuclear layer morphology / IMPC
- decreased circulating serum albumin level / IMPC
- decreased mean corpuscular volume / IMPC
- decreased circulating glucose level / IMPC
- increased prepulse inhibition / IMPC
- fibro-osseous lesion / IMPC
- increased lung compliance / IMPC
- decreased respiratory quotient / IMPC
- abnormal sleep behavior / IMPC
- unresponsive to tactile stimuli / IMPC
- increased cardiac muscle contractility / IMPC
- abnormal behavior / IMPC
- increased circulating creatine kinase level / IMPC
- limb grasping / IMPC
- increased circulating free fatty acids level / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- decreased thigmotaxis / IMPC
- hypoplasia / IMPC
- abnormal coat appearance / IMPC
- increased kidney weight / IMPC
- decreased circulating total protein level / IMPC
- increased erythrocyte cell number / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- abnormal inspiratory capacity / IMPC
- impaired glucose tolerance / IMPC
- small testis / IMPC
- increased circulating amylase level / IMPC
- decreased anxiety-related response / IMPC
- decreased circulating triglyceride level / IMPC
- abnormal vertebrae morphology / IMPC
- cardiovascular system phenotype / IMPC
- increased circulating alkaline phosphatase level / IMPC
- decreased cardiac output / IMPC
- decreased heart rate variability / IMPC
- increased bone mineral density / IMPC
- abnormal freezing behavior / IMPC
- abnormal sinus arrhythmia / IMPC
- decreased circulating alanine transaminase level / IMPC
- depletion / IMPC
- enlarged lymph nodes / IMPC
- increased hemoglobin content / IMPC
- enlarged spleen / IMPC
- process of degenerative change / IMPC
- increased red blood cell distribution width / IMPC
- decreased locomotor activity / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased heart weight / IMPC
- increased hematocrit / IMPC
- impaired contextual conditioning behavior / IMPC
- decreased circulating creatinine level / IMPC
- decreased circulating free fatty acids level / IMPC
- abnormal kidney morphology / IMPC
- decreased hemoglobin content / IMPC
- increased exploration in new environment / IMPC
- increased fasting circulating glucose level / IMPC
C57BL/6N-Ap4e1tm1c(KOMP)Wtsi/H
Status | Available to order |
EMMA ID | EM:09035 |
International strain name | C57BL/6N-Ap4e1tm1c(KOMP)Wtsi/H |
Alternative name | EPD0025_5_A08 |
Strain type | Targeted Mutant Strains : Targeted Conditional |
Allele/Transgene symbol | Ap4e1tm1c(KOMP)Wtsi |
Gene/Transgene symbol | Ap4e1 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This line originates from KOMP ES clone EPD0025_5_A08, after breeding with a Flp recombinase deleter line to convert the original targeted allele tm1a (knock-out first allele) into a conditional allele tm1c. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Severe intellectual disability and progressive spastic paraplegia / Orphanet_280763
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- increased bone mineral density / MGI
- abnormal femur morphology / MGI
- decreased corpus callosum size / MGI
- anemia / MGI
- decreased vertical activity / MGI
- decreased hemoglobin content / MGI
- increased lean body mass / MGI
- abnormal behavior / MGI
- decreased mean corpuscular hemoglobin / MGI
- enlarged lateral ventricles / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).